Trimetazidine
Metabolic Health · Cardiac metabolic modulator
Tier D+
Bottom line
Read Off Label grades Trimetazidine as D+ (3.9/10) based on weak evidence, low-med benefit magnitude, and a med-risk safety profile.
Added from WADA S4.
Studied, labeled, or reported-use context: Clinical dosing varies by country/formulation; no performance dose — Rx in some countries for angina; not FDA-approved; WADA S4 prohibited; not individualized guidance.
What the evidence says
Added from WADA S4.4.4. This is best understood as a cardiac metabolic drug that became a doping concern, not a general metabolic-health intervention.
Mechanism
Trimetazidine shifts myocardial substrate use toward glucose oxidation; sport use is framed as endurance/ischemia-resilience enhancement, but healthy-performance evidence is weak.
Studied, labeled, or reported dose & route
Clinical dosing varies by country/formulation; no performance dose
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Trimetazidine's effects?
- Read Off Label rates the evidence for Trimetazidine as Weak and the benefit magnitude as low-med, producing an overall grade of D+ (3.9/10). Added from WADA S4.
- What safety findings are reported for Trimetazidine?
- Trimetazidine has a med risk profile in the database. Med (movement disorders/parkinsonism warning, dizziness, GI effects, sport/legal risk) Legal status: Rx in some countries for angina; not FDA-approved; WADA S4 prohibited.
- What doses or routes are reported for Trimetazidine?
- Clinical dosing varies by country/formulation; no performance dose This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Trimetazidine work?
- Trimetazidine shifts myocardial substrate use toward glucose oxidation; sport use is framed as endurance/ischemia-resilience enhancement, but healthy-performance evidence is weak.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.